| dc.contributor.author | Kaur-Bring, Narinder | |
| dc.date.accessioned | 2015-05-14T13:05:41Z | |
| dc.date.available | 2015-05-14T13:05:41Z | |
| dc.date.issued | 2012-04 | |
| dc.identifier.citation | Kaur-Bring , N 2012 , ' A Multidisciplinary Audit on the Safe Discharge of Patients on Insulin from Bedford Hospital. ' , Clinical Pharmacist , no. S2 , pp. S4 . < http://www.ukcpa.net/wp-content/uploads/2012/06/Autumn-Symposium-November-2011.pdf > | |
| dc.identifier.other | PURE: 8550690 | |
| dc.identifier.other | PURE UUID: a9fd50b3-869c-4562-95f3-5e135a74cbf0 | |
| dc.identifier.uri | http://hdl.handle.net/2299/15926 | |
| dc.description | Sanofi Aventis Diabetes Award 2011 | |
| dc.description.abstract | Insulin is a high-risk drug for serious or fatal outcomes.1 The National Patient Safety Agency recorded more than 13,000 insulin-related reports from November 2003 to March 2009. The most common insulin errors related to dose (strength/frequency), omission, incorrect medication and quantity | en |
| dc.format.extent | 1 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Clinical Pharmacist | |
| dc.subject | diabetes | |
| dc.subject | audit | |
| dc.subject | checklist | |
| dc.title | A Multidisciplinary Audit on the Safe Discharge of Patients on Insulin from Bedford Hospital. | en |
| dc.contributor.institution | Department of Pharmacy | |
| dc.contributor.institution | Health & Human Sciences Research Institute | |
| dc.contributor.institution | School of Life and Medical Sciences | |
| dc.contributor.institution | Centre for Clinical Practice, Safe Medicines and Drug Misuse Research | |
| dc.description.status | Peer reviewed | |
| dc.identifier.url | http://www.ukcpa.net/wp-content/uploads/2012/06/Autumn-Symposium-November-2011.pdf | |
| rioxxterms.type | Other | |
| herts.preservation.rarelyaccessed | true | |
